RareCyte
Seattle, United States · Founded 2006 · $72.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- rarecyte.com
- Total Funding
- $72.0M
- Last Round
- $20.0M Series CJun 2024
- Rounds
- 3
About
Life sciences company providing automated imaging instruments and tools for rare cell detection, retrieval, and single-cell analysis.
Summary
RareCyte is a Biotech company based in Seattle, United States, founded in 2006. It has raised $72.0M in total across 3 rounds, most recently a $20.0M Series C round in Jun 2024. Investors include Arboretum Ventures, F-Prime Capital and HealthQuest Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...